Tenet Q4 EPS $3.32 (adj. $3.44); FY2025 adj. EBITDA guidance $3.975-4.175B

TENET HEALTHCARE CORP

2024-FY EPS reported $32.70 revenue$20,665,000,000

Q4 net income $318M ($3.32 diluted); adjusted EPS $3.44 vs $2.68 year ago.
Q4 net operating revenue $5.072B (down 5.7% YoY from $5.379B on hospital divestitures).
Q4 consolidated adjusted EBITDA $1.048B (20.7% margin); Ambulatory adj. EBITDA up 14.2% to $530M.
FY2025 outlook: adj. EBITDA $3.975-4.175B, adj. EPS $11.74-12.84, free cash flow $1.8-2.05B.
Net debt-to-adjusted EBITDA improved to 2.54x at Dec 31, 2024; repurchased 5.6M shares for $672M in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.